SelectQuote (NYSE:SLQT - Get Free Report) is expected to be issuing its Q3 2025 quarterly earnings data before the market opens on Thursday, May 8th. Analysts expect the company to announce earnings of $0.04 per share and revenue of $412.83 million for the quarter. SelectQuote has set its FY 2025 guidance at EPS.
SelectQuote (NYSE:SLQT - Get Free Report) last released its quarterly earnings data on Monday, February 10th. The company reported $0.30 EPS for the quarter, beating the consensus estimate of $0.09 by $0.21. SelectQuote had a negative net margin of 0.95% and a negative return on equity of 4.38%. On average, analysts expect SelectQuote to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
SelectQuote Trading Down 4.0 %
Shares of SelectQuote stock opened at $3.16 on Thursday. The stock has a market cap of $543.98 million, a PE ratio of -35.11 and a beta of 1.25. The firm has a fifty day moving average price of $3.54 and a 200 day moving average price of $3.45. SelectQuote has a 1 year low of $1.48 and a 1 year high of $6.86. The company has a debt-to-equity ratio of 2.10, a current ratio of 6.36 and a quick ratio of 6.36.
Insider Buying and Selling at SelectQuote
In other news, insider Sarah Taylor Anderson sold 50,000 shares of the stock in a transaction that occurred on Thursday, February 20th. The stock was sold at an average price of $5.44, for a total transaction of $272,000.00. Following the transaction, the insider now owns 1,166 shares in the company, valued at $6,343.04. This trade represents a 97.72 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 11.40% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
Separately, Noble Financial raised SelectQuote to a "strong-buy" rating in a report on Wednesday, February 12th.
Get Our Latest Report on SelectQuote
SelectQuote Company Profile
(
Get Free Report)
SelectQuote, Inc operates a technology-enabled, direct-to-consumer distribution platform that sells a range of insurance products and healthcare services in the United States. The company operates through three segments: Senior; Life; and Auto & Home. It distributes senior health policies, such as medicare advantage, medicare supplement, medicare part D, and other ancillary senior health insurance related products, including prescription drugs, dental, vision, and hearing plans; life insurance products, such as term life, final expense, and other ancillary products, including critical illness, accidental death, and juvenile insurance; homeowners, auto, dwelling fire, and other ancillary insurance products; and non-commercial auto and home property, and casualty policies.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SelectQuote, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SelectQuote wasn't on the list.
While SelectQuote currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
